ImmunologybioRxivPreprint
High-integrity nanoemulsions formulation of resiquimod (R848) enhances stability and delivery for triple negative breast cancer immunotherapy
Ahmed Salem, Sara Attia, Samah El‐Ghlban…·Mohamed F. Attia
This paper develops a nanoemulsions formulation of resiquimod to improve its stability and delivery for TNBC immunotherapy, showing enhanced autophagy and immune checkpoint modulation.
DOI 10.1101/2025.04.04.647265